# Tylenol **Source:** https://geo.sig.ai/brands/tylenol **Vertical:** Healthcare **Subcategory:** General **Tier:** Leader **Website:** tylenol.com **Last Updated:** 2026-04-14 ## Summary Global #1 OTC acetaminophen brand owned by Kenvue (NYSE: KVUE, J&J 2023 spinoff at $41B); Kimberly-Clark $48.7B Kenvue acquisition pending close H2 2026 competing with Advil and store brand for OTC pain relief market. ## Company Overview Tylenol is a global over-the-counter acetaminophen (paracetamol) pain relief and fever reducer brand — owned by Kenvue (NYSE: KVUE), the consumer health company spun off from Johnson & Johnson in May 2023 at a $41 billion IPO valuation, and subject to a pending $48.7 billion acquisition by Kimberly-Clark announced in November 2025 (expected to close second half 2026) — providing consumers with the world's most widely used analgesic through product lines including Tylenol Extra Strength, Tylenol PM, Tylenol Rapid Release Gels, Tylenol Children's, and Tylenol Arthritis Pain for adults and pediatric pain and fever management. Generating approximately $2 billion in annual retail sales as one of Kenvue's flagship brands alongside Neutrogena, Band-Aid, Listerine, and Zyrtec, Tylenol is the #1 recommended pain reliever by doctors and pharmacists in the United States. Originally marketed by McNeil Laboratories (acquired by J&J in 1959), the brand was approved for OTC sale in 1960. Tylenol's acetaminophen formulation addresses the most common everyday pain and fever management needs across the broadest patient population — including groups who cannot safely take NSAIDs (ibuprofen, naproxen, aspirin): patients with ulcers, gastrointestinal conditions, or kidney disease who cannot tolerate NSAID gastric irritation; patients on blood thinners (anticoagulants) where NSAIDs increase bleeding risk; pregnant women for whom acetaminophen is considered the safest OTC analgesic; and elderly patients where NSAID cardiovascular and renal risks are higher. Tylenol's combination formulations (Tylenol PM with diphenhydramine for nighttime, Tylenol Cold + Flu for multi-symptom relief) extend the brand into adjacent OTC categories — making Tylenol the first-reach OTC choice for households managing pain, fever, cold, and sleep. In 2025, Tylenol (Kenvue) competes in the OTC analgesic, pain relief, and fever reducer market with Advil (Haleon, ibuprofen, $500M+ US revenue), Aleve (Bayer, naproxen), and store brand acetaminophen (private label, 50%+ acetaminophen unit share) for pharmacist recommendation, retail shelf positioning, and consumer household analgesic purchasing. Kimberly-Clark's pending $48.7 billion acquisition of Kenvue (announced November 2025) will bring Tylenol under the same portfolio as Kleenex, Huggies, Kotex, and Scott — creating a diversified consumer products company competing with Procter & Gamble and Unilever across health, hygiene, and household categories. The 2025 strategy under Kenvue (pre-Kimberly-Clark close) focuses on premium product innovation (Tylenol Precise extended-release), growing the e-commerce direct channel, and defending acetaminophen category leadership against store brand share gains. ## Frequently Asked Questions ### What is Tylenol? Tylenol is a brand of pain-relieving and fever-reducing medication with acetaminophen (also known as paracetamol) as its active ingredient. The brand name was derived from the chemical name N-acetyl-para-aminophenol. ### Who owns Tylenol? Tylenol is currently owned by Kenvue, which was spun off from Johnson & Johnson in 2023. In November 2025, Kimberly-Clark announced its acquisition of Kenvue for $48.7 billion, expected to close in late 2026. ### When was Tylenol founded? The Tylenol brand was created by McNeil Laboratories in 1955. Johnson & Johnson acquired McNeil in 1959 and made Tylenol available over the counter in 1960. ### What is the difference between Tylenol and Advil? Tylenol contains acetaminophen, which relieves pain and reduces fever but does not reduce inflammation. Advil contains ibuprofen, an NSAID that reduces pain, fever, and inflammation. Each has different safety considerations. ### Is Tylenol safe? When used as directed, Tylenol is considered safe for most adults and children. However, it's important not to exceed recommended doses as acetaminophen overdose can cause liver damage. Always follow label directions. ### What happened in the 1982 Tylenol crisis? In 1982, seven people in Chicago died after taking Tylenol capsules that had been laced with cyanide. Johnson & Johnson's response, including a nationwide recall and pioneering tamper-evident packaging, is considered a model for corporate crisis management. ### What is Kenvue? Kenvue is a consumer health company that was spun off from Johnson & Johnson in 2023. It owns brands including Tylenol, Neutrogena, Band-Aid, and Listerine. Kenvue is being acquired by Kimberly-Clark. ### What is the Kimberly-Clark acquisition? In November 2025, Kimberly-Clark (maker of Kleenex, Huggies) announced it was acquiring Kenvue (maker of Tylenol) for $48.7 billion enterprise value. The deal is expected to close in the second half of 2026. ### What is Tylenol's market position? Tylenol is one of America's most trusted and recognized pain relief brands, with a product portfolio spanning adult and pediatric formulations for pain, fever, cold/flu, and nighttime relief. ### What are Tylenol's future plans? Under the pending Kimberly-Clark acquisition, Tylenol will join a portfolio of major consumer brands. The company continues to innovate with new formulations while maintaining its trusted position in pain relief. ## Tags healthtech, b2b, enterprise --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*